Speciality Medicines IPO Day 1 Subscription Status: Subscribed 0.82x
By HDFC SKY | Published at: Mar 20, 2026 05:32 PM IST
Speciality Medicines IPO subscribed 0.82x on Day 1 with NII leading demand: he offering comprises a fresh issue of 23.5 lakh shares. The price band has been fixed at ₹117 to ₹124 per share.
Mumbai, March 20: Speciality Medicines IPO, a ₹29.14 crore book-built issue, opened for subscription on March 20, 2026, and will close on March 24, 2026. The offering comprises a fresh issue of 23.5 lakh shares. The price band has been fixed at ₹117 to ₹124 per share.
The IPO is proposed to list on the BSE SME platform, with the tentative listing date scheduled for March 30, 2026. The basis of allotment is expected to be finalised on March 25, 2026.
Speciality Medicines IPO Day 1 Subscription Status
As of 4:44 PM on March 20, 2026 (Day 1), the Speciality Medicines IPO was subscribed 0.82 times.
Category-wise Speciality Medicines IPO Subscription Status
| Category | Subscription (x) | Shares Offered | Shares Bid For |
| QIB (Ex Anchor) | 1.00 | 21,000 | 21,000 |
| NII (HNI) | 1.57 | 10,89,000 | 17,12,000 |
| bNII (> ₹10L) | 2.32 | 7,26,000 | 16,87,000 |
| sNII (< ₹10L) | 0.07 | 3,63,000 | 25,000 |
| Retail Investors | 0.07 | 10,90,000 | 72,000 |
| Total | 0.82 | 22,00,000 | 18,05,000 |
Speciality Medicines Day-wise Subscription Summary
| Date | QIB | NII | bNII | sNII | Retail | Total |
| March 20 (Day 1) | 1.00 | 1.57 | 2.32 | 0.07 | 0.07 | 0.82 |
Speciality Medicines IPO Timeline
| Event | Date |
| Issue Open Date | March 20 2026 |
| Issue Close Date | March 24 2026 |
| Basis of Allotment | March 25 2026 |
| Initiation of Refunds | March 27 2026 |
| Credit of Shares | March 27 2026 |
| Listing Date | March 30 2026 |
Brief Overview Of The IPO
Speciality Medicines IPO is a ₹29.14 crore issue consisting entirely of a fresh issue of 23,50,000 shares. The price band is set at ₹117 to ₹124 per share, with a lot size of 1,000 shares.
The minimum investment for retail investors stands at ₹2,48,000 for two lots, while HNI investors are required to apply for a minimum of three lots amounting to ₹3,72,000.
Incorporated in 2021, Speciality Medicines Limited operates in the marketing and distribution of speciality pharmaceutical formulations, including treatments for chronic and complex conditions across domestic and international markets.
Source:
https://www.bseindia.com/markets/publicIssues/DisplayIPO.aspxid=4512&type=IPO&idtype=1&status=L&IPONo=7653&startdt=20/Mar/2026
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
